Market Research Logo

Taiwan Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical andhealthcare investment, but is not without flaws. Weaknesses in the country's regulatory regime and drugpricing concerns will continue to deter multinational interest over our forecast period. Because of the localcurrency depreciation, the forecasts for Q215 are slightly down.

Headline Expenditure Projections

Pharmaceuticals: TWD167.74bn (USD5.53bn) in 2014 to TWD175.07bn (USD5.56bn) in 2015; +4.4%in local currency terms and +0.5% in US dollar terms. Local currency forecast unchanged fromprevious quarter. USD forecast down sharply due to local currency depreciation.

Healthcare: TWD1004.53bn (USD33.12bn) in 2014 to TWD1045.28bn (USD33.18bn) in 2015; +4.1%in local currency terms and +0.2% in US dollar terms. Local currency forecast down slightly,compared to the Q115 projection. USD forecast down more sharply due to local currencydepreciation.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Taiwan 2011-2019)
Healthcare Market Forecast
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Taiwan 2011-2019)
Patented Drug Market Forecast
Table: Top 10 Pharmaceuticals In Taiwan According To BNHI Expenditure In 2008
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Taiwan 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Taiwan 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Taiwan 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Taiwan 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Taiwan 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: Economic Activity (Taiwan 2010-2019)
Industry Risk Reward Ratings
Asia Pacific Risk/Reward Index
Taiwan Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare System
Healthcare Insurance
Table: Sources Of Financing
Table: Healthcare Resources
Table: Healthcare Activity
Table: Healthcare Personnel
Healthcare Financing
Table: Taiwan Insurance Coverage
Medical Tourism
Traditional Chinese Medicine
Biotechnology Sector
Vaccines
Clinical Trials
Telecare
Regulatory Development
Table: Medicine Categories In Taiwan
Table: Examples Of Controlled Drugs In Taiwan
Recent Regulatory Developments
Intellectual Property Regime
Pricing Regime
Reimbursement Regime
Table: Reimbursement System in Taiwan
Table: Drug Reimbursement Principles
Table: BNHI Spending By Type Of Outpatient Claims, As Percentage Of Total
Competitive Landscape
Pharmaceutical Industry
Table: Western & TCM Manufacturers, 2006-10
Table: Pharmaceutical Output Value by Type, 2002-2010 (USDmn)
Domestic Pharmaceutical Sector
Table: Top-20 Pharmaceutical & Biotechnology Firms In Taiwan According To Market Capitalisation (USDmn)
Table: TGPA Members, 2012
Foreign Pharmaceutical Sector
Table: Corporate Members Of Taiwan's IRPMA, 2012
Pharmaceutical Wholesale
Table: Western Drug Distributors 2006-2010
Pharmaceutical Retail
Table: Pharmacies, 2006-2010
Company Profile
Yung Shin Pharmaceutical (YSP)
ScinoPharm Taiwan
Empax Pharma
TaiGen
Pfizer
Sanofi
GlaxoSmithKline (GSK)
Novartis
Merck & Co
Demographic Forecast
Table: Population Headline Indicators (Taiwan 1990-2025)
Table: Key Population Ratios (Taiwan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Taiwan 1990-2025)
Table: Population By Age Group (Taiwan 1990-2025)
Table: Population By Age Group % (Taiwan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report